Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

Unknown Ankylos CX abutment: medical device reports filed with FDA

272 reports name it, 2021–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

272
device reports naming the brand
0% of all MAUDE reports · about 51 a year
139
reports, 12 months to August 2026
33 in the 12 months before
11.4%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

272 medical device reports received by FDA name the brand "Unknown Ankylos CX abutment" (implant endosseous root-form); the manufacturer given most often on reports is Dentsply Implants Manufacturing; received from March 2021 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

139 reports arrived in the 12 months to August 2026, up 321% from 33 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (88.6%) and malfunction (11.4%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are fracture (91.9%), osseointegration problem (6.3%) and loss of osseointegration (1.1%). The patient problems coded most often are failure of implant, inflammation and pocket erosion. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01937Sep 2021: 1Oct 2021: 1Nov 2021: 2Dec 2021: 02022Jan 2022: 0Feb 2022: 1Mar 2022: 6Apr 2022: 2May 2022: 3Jun 2022: 1Jul 2022: 4Aug 2022: 1Sep 2022: 2Oct 2022: 6Nov 2022: 1Dec 2022: 42023Jan 2023: 6Feb 2023: 3Mar 2023: 2Apr 2023: 2May 2023: 4Jun 2023: 2Jul 2023: 5Aug 2023: 4Sep 2023: 1Oct 2023: 2Nov 2023: 1Dec 2023: 22024Jan 2024: 5Feb 2024: 0Mar 2024: 1Apr 2024: 4May 2024: 3Jun 2024: 0Jul 2024: 3Aug 2024: 3Sep 2024: 2Oct 2024: 2Nov 2024: 1Dec 2024: 02025Jan 2025: 1Feb 2025: 4Mar 2025: 5Apr 2025: 5May 2025: 1Jun 2025: 6Jul 2025: 2Aug 2025: 4Sep 2025: 3Oct 2025: 5Nov 2025: 1Dec 2025: 152026Jan 2026: 23Feb 2026: 37Mar 2026: 16Apr 2026: 11May 2026: 2Jun 2026: 8Jul 2026: 14Aug 2026: 4

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0581152021: 1620212022: 3120222023: 3420232024: 2420242025: 5220252026: 1152026

Event type and report source

Event type, as classified on the report

Death0%0
Injury88.6%241
Malfunction11.4%31
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%272
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Fracturea broken bone25091.9%1.6%
Osseointegration problem176.3%7.7%
Loss of osseointegration31.1%22.4%
Failure to osseointegrate20.7%62.8%
Separation failure20.7%0.1%
Insufficient device problem information10.4%0.2%
Mechanical problema mechanical problem10.4%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant18969.5%
Inflammationinflammation51.8%
Pocket erosion20.7%
Osteolysis10.4%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureUnknown Ankylos CX abutmentProduct code DZEAll MAUDE reports
Reports2723,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury88.6%99.2%36.2%
Classified as malfunction11.4%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Unknown Ankylos CX abutment reports

How many FDA reports name Unknown Ankylos CX abutment?

272 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 139 in the latest 12 months.

What kinds of events are reported?

injury (88.6%) and malfunction (11.4%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

fracture (91.9%), osseointegration problem (6.3%), loss of osseointegration (1.1%), failure to osseointegrate (0.7%) and separation failure (0.7%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Unknown Ankylos CX abutment was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.